Private Company Director’s Directors to Watch 2025 highlights 31 significant and diverse directors who have contributed to and will continue to expand ongoing dialogue on board best practices and corporate governance excellence.
Kate Hermans
Clue by Biowink, Mid-Atlantic Diamond Ventures
Kate Hermans has spent her career successfully leading cross-functional teams to build, transform and accelerate the growth of a diverse suite of businesses.
She is a strategic advisor and nonexecutive director of both venture-backed and public biotech and healthtech companies. She is chair of Clue by BioWink, director of Mid-Atlantic Diamond Ventures, and an advisory board member of Women’s Resource Center. Hermans recently exited the board of Ambrx Biopharma, following Johnson & Johnson’s acquisition, having served as CEO in 2022, reset the company’s strategy, streamlined company operations and onboarded a new CEO.
Previously, Hermans held executive business leadership roles at 83bar, Radius Health, Bristol-Myers Squibb, Pfizer and Intel, working in the United States, China and Africa.
Good corporate governance is the bedrock of sustainable success: “All directors must have the knowledge and confidence to prioritize transparency, accountability and ethical decision-making, ensuring that every strategic decision aligns with long-term value creation. By fostering a culture of innovation and trust at the board and management levels, effective directors champion robust risk management, rigorous compliance and diverse perspectives to balance stakeholder interests, while also promoting integrity and strategic alignment, driving impactful solutions and ensuring effective communication. Holding oneself accountable to the highest standards, while advocating for socially responsible practices that deliver growth, resilience and enduring impact, is key.”